GRDN — Guardian Pharmacy Services Cashflow Statement
0.000.00%
- $1.58bn
- $1.57bn
- $1.23bn
- 97
- 34
- 55
- 68
Annual cashflow statement for Guardian Pharmacy Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 29.7 | 28.3 | 49.7 | 37.7 | -71 |
| Depreciation | |||||
| Non-Cash Items | 6.79 | 15.1 | 1.02 | -0.737 | 139 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.09 | -1.47 | -18.7 | 15.6 | -29.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 52.6 | 58.5 | 48.5 | 70.8 | 58 |
| Capital Expenditures | -8.34 | -9.28 | -16.8 | -14.6 | -16.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3.84 | -3.87 | -1.13 | 1.11 | -14 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.2 | -13.1 | -17.9 | -13.4 | -30.4 |
| Financing Cash Flow Items | -20.9 | -30.7 | -42.2 | -54.3 | 12.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -34.3 | -36.8 | -45 | -57.2 | -23.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.17 | 8.56 | -14.4 | 0.145 | 3.91 |